Companies: 10,795·Total market cap: $144.5T
DermTech, Inc.

DermTech, Inc.

DMTKQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$3496
P/E Ratio
52W High$0.059
52W Low$0.00001
Overview

DermTech, Inc. (DMTKQ) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

dmtkq · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for DermTech, Inc. (DMTKQ) measures how much investors pay for each dollar of the company's trailing earnings. DMTKQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$3.09.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2026 est. EPS $-1.07
Based on 1 analyst
EPS (TTM)
-$3.09
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DermTech, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2023 · Annual
PE Ratio (TTM)
5Y Avg 209.3x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
DermTech, Inc.
DermTech, Inc.You
DMTKQ
$0MN/A-$3.09
American Bio Medica Corporation
American Bio Medica Corporation
ABMC
$0MN/A-$0.03
Allied Healthcare Products, Inc.
Allied Healthcare Products, Inc.
AHPIQ
$0MN/A
American CryoStem Corporation
American CryoStem Corporation
CRYO
$0MN/A-$0.05
ER Urgent Care Holdings, Inc.
ER Urgent Care Holdings, Inc.
ERUC
$0MN/A
GeneThera, Inc.
GeneThera, Inc.
GTHR
$0MN/A-$0.04
Global WholeHealth Partners Corporation
Global WholeHealth Partners Corporation
GWHP
$0MN/A-$0.05

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-3.09
2022-12-31
FY2022
$-3.88
2021-12-31
FY2021
$-2.71
2020-12-31
FY2020
$-2.15
2019-12-31
FY2019
$-2.87
2018-03-31
FY2018
209.29x$0.09
2017-03-31
FY2017
$-0.00
2016-03-31
FY2016
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for DermTech, Inc. (DMTKQ) measures how much investors pay for each dollar of the company's trailing earnings. DMTKQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$3.09.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$3.09 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

DMTKQ pe ratio · 6 questions

DMTKQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$3.09. Data sourced from Financial Modeling Prep via DMTKQ's SEC 10-K and 10-Q filings.

DMTKQ PE ratioWhat is DMTKQ PE ratioCurrent PE ratio of DMTKQDMTKQ PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DermTech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09